Conference item icon

Conference item

Outcomes of relapsed/refractory patients with IDH1/2 mutated AML treated with non-targeted therapy: results from the NCRI AML trials

Publication status:
Published
Peer review status:
Reviewed (other)

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Nuffield Dept of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
ORCID:
0000-0003-0166-0062
Publisher:
American Society of Hematology
Host title:
Blood
Journal:
Blood More from this journal
Volume:
132
Issue:
Supplement 1
Article number:
664
Publication date:
2018-11-21
Acceptance date:
2018-10-01
DOI:
EISSN:
1528-0020
ISSN:
0006-4971
Keywords:
Pubs id:
pubs:980217
UUID:
uuid:1ce3e5dc-a83a-4006-a921-ed03324791c8
Local pid:
pubs:980217
Source identifiers:
980217
Deposit date:
2019-04-04

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP